{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:11Z","timestamp":1787026931911,"version":"build-2736575974"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Hypertrophic pachymeningitis associated with immunoglobulin G4-related disease (IgG4-RD) has been rarely reported, and there is little information and no clear consensus on the management of IgG4-related spinal pachymeningitis (IgG4-RSP). The present study described its possible clinical features, including the symptoms, imaging, treatment and prognosis of patients with IgG4-RSP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We report three patients who presented with progressive neurological dysfunction due to spinal cord compression. Relevant articles were searched from the PubMed, Web of Science, and Embase databases, and the resulting literature was reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The literature review provided a summary of 45 available cases, which included three cases from our center. Progressive worsening of neurological impairment was observed in 22 patients (48.9%). The lesions involved the thoracic spine (\n                      <jats:italic>n<\/jats:italic>\n                      =28, 62.2%), cervical spine (\n                      <jats:italic>n<\/jats:italic>\n                      =26, 57.8%), lumbar spine (\n                      <jats:italic>n<\/jats:italic>\n                      =9, 20.0%), and sacral spine (\n                      <jats:italic>n<\/jats:italic>\n                      =1, 2.2%). Furthermore, the lesions were located in the dura mater (\n                      <jats:italic>n<\/jats:italic>\n                      =18, 40.0%), epidural space (\n                      <jats:italic>n<\/jats:italic>\n                      =17, 37.8%), intradural-extramedullary space (\n                      <jats:italic>n<\/jats:italic>\n                      =9, 20.0%), and intramedullary space (\n                      <jats:italic>n<\/jats:italic>\n                      =1, 2.2%). On magnetic resonance imaging (MRI), the lesions generally appeared as striated, fusiform, or less often lobulated oval changes, with homogeneous (\n                      <jats:italic>n<\/jats:italic>\n                      =17,44.7%) and dorsal (\n                      <jats:italic>n<\/jats:italic>\n                      =15,39.5%) patterns being the most common. Thirty-five patients had homogeneous T1 gadolinium enhancement. Early surgical decompression, corticosteroid treatment, and steroid-sparing agents offered significant therapeutic advantages. A good therapeutic response to disease recurrence was observed with the medication.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The number of reported cases of IgG4-RSP remains limited, and patients often have progressive worsening of their neurological symptoms. The features of masses identified on the MRI should be considered. The prognosis was better with decompression surgery combined with immunosuppressive therapy. Long-term corticosteroid treatment and steroid-sparing agent maintenance therapy should be ensured. A systemic examination is recommended to identify the presence of other pathologies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2022.1035056","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T16:18:06Z","timestamp":1673367486000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Case report: Clinical highlights and radiological classification of IgG4-related spinal pachymeningitis: A rare case series and updated review of the literature"],"prefix":"10.3389","volume":"12","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.5.683","article-title":"Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis","volume":"52","author":"Kamisawa","year":"2003","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","article-title":"A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2019.08.009","article-title":"Review of IgG4-related disease","volume":"42","author":"S\u00e1nchez-Oro","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2015-001315","article-title":"Intracranial spread of IgG4-related disease via skull base foramina","volume":"16","author":"Rice","year":"2016","journal-title":"Pract Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"401890","DOI":"10.1155\/2012\/401890","article-title":"IgG4-related perineural disease","volume":"2012","author":"Inoue","year":"2012","journal-title":"Int J Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3104-x","article-title":"IgG4-related spinal pachymeningitis","volume":"35","author":"Lu","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181abdfc2","article-title":"IgG4-related sclerosing pachymeningitis: A previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease","volume":"33","author":"Chan","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.07.227","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis of the spine: A case report and systematic review of the literature","volume":"143","author":"Sbeih","year":"2020","journal-title":"World Neurosurg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f73614","article-title":"IgG4-related sclerosing pachymeningitis causing spinal cord compression","volume":"75","author":"Choi","year":"2010","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0746-2","article-title":"IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria","volume":"120","author":"Lindstrom","year":"2010","journal-title":"Acta Neuropathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-5-201203060-00025","article-title":"IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis","volume":"156","author":"Della Torre","year":"2012","journal-title":"Ann Internal Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-006471","article-title":"Cranial neuropathy because of IgG4-related pachymeningitis; intracranial and spinal mass lesions","volume":"2012","author":"Tajima","year":"2012","journal-title":"BMJ Case Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-related disease and hypertrophic pachymeningitis","volume":"92","author":"Wallace","year":"2013","journal-title":"Medicine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130678","article-title":"Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis","volume":"40","author":"Della-Torre","year":"2013","journal-title":"J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5535\/arm.2014.38.6.856","article-title":"Paraplegia in a patient with IgG4-related sclerosing disease: A case report","volume":"38","author":"Kim","year":"2014","journal-title":"Ann Rehabil Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.54.664","article-title":"IgG4-related disease that presented cranial, cervical, lumbar and sacral hypertrophic pachymeningitis associated with infundibulo-hypophysitis","volume":"54","author":"Sakai","year":"2014","journal-title":"Rinsho Shinkeigaku"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100017364","article-title":"IgG4-related disease presenting as dural thickening - a rare cause of myelopathy","volume":"41","author":"Zwicker","year":"2014","journal-title":"Can J Neurol Sci Le J canadien Des Sci neurologiques"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.128816","article-title":"A mysterious back pain","volume":"60","author":"Chen","year":"2014","journal-title":"J Postgraduate Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jns.2014.10.012","article-title":"Hypertrophic spinal pachymeningitis: idiopathic vs","volume":"347","author":"Ezzeldin","year":"2014","journal-title":"IgG4-related. J Neurol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13256-016-0838-2","article-title":"IgG4-related disease presenting with an epidural inflammatory pseudotumor: A case report","volume":"10","author":"Ferreira","year":"2016","journal-title":"J Med Case Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3171\/2016.4.SPINE1674","article-title":"An orphan disease: IgG4-related spinal pachymeningitis: report of 2 cases","volume":"25","author":"Radotra","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"B24","article-title":"IgG4-related cranio-spinal hypertrophic pachymeningitis involving the internal auditory canal","volume":"30","author":"Yangue","year":"2016","journal-title":"J Biol Regulators Homeostatic Agents"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001872","article-title":"FDG PET\/CT in immunoglobulin G4-related spinal hypertrophic pachymeningitis","volume":"42","author":"Zhao","year":"2017","journal-title":"Clin Nucl Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12739","article-title":"Alteration of IgG4 levels in cerebrospinal fluid in IgG4-related disease","volume":"20","author":"Fern\u00e1ndez-Codina","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3171\/2016.5.SPINE16119","article-title":"Immunoglobulin G4-related disease mimicking an epidural spinal cord tumor: case report","volume":"26","author":"Williams","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2017.07.012","article-title":"IgG4-related hypertrophic pachymeningitis of the spine with MPO-ANCA seropositivity","volume":"46","author":"Maher","year":"2017","journal-title":"Clin Imag"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/02688697.2017.1384793","article-title":"IgG4-related disease presenting as intradural extramedullary lesion: A case report and review of the literature","volume":"33","author":"Bridges","year":"2019","journal-title":"Br J Neurosurg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3171\/2016.11.SPINE16924","article-title":"Immunoglobulin G4-related epidural inflammatory pseudotumor presenting with pulmonary complications and spinal cord compression: case report","volume":"26","author":"Rumalla","year":"2017","journal-title":"J Neurosurg. Spine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1971400917698173","article-title":"Neurological involvement of IgG4-related disease: description of a case and review of the literature","volume":"31","author":"Varrassi","year":"2018","journal-title":"neuroradiology J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4103\/sni.sni_156_18","article-title":"Neuro-surgical considerations for treating IgG4-related disease with rare spinal epidural compression","volume":"9","author":"Winkel","year":"2018","journal-title":"Surg Neurol Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-018-3689-3","article-title":"Clinical features of hypertrophic pachymeningitis in a center survey","volume":"40","author":"Ca\u00e7\u00e3o","year":"2019","journal-title":"Neurological Sci Off J Ital Neurological Soc Ital Soc Clin Neurophysiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000568","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review","volume":"6","author":"Levraut","year":"2019","journal-title":"Neurology(R) Neuroimmunol Neuroinflamm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3618510","DOI":"10.1155\/2019\/3618510","article-title":"IgG4-related sclerosing disease causing spinal cord compression: The first reported case in literature","volume":"2019","author":"Merza","year":"2019","journal-title":"Case Rep Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_283_18","article-title":"A series of biopsy-proven patients with immunoglobulin G4-related neurological disease","volume":"22","author":"Sireesha","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.wneu.2019.06.130","article-title":"Spinal IgG4-related hypertrophic pachymeningitis with spinal cord compression: Case report and literature review","volume":"130","author":"Slade","year":"2019","journal-title":"World Neurosurg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.05.003","article-title":"Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review","volume":"49","author":"Melenotte","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04502-6","article-title":"Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review","volume":"40","author":"Vakrakou","year":"2020","journal-title":"Rheumatol Int"},{"key":"B40","doi-asserted-by":"publisher","first-page":"577325","DOI":"10.1016\/j.jneuroim.2020.577325","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis with spinal cord compression: A case report","volume":"347","author":"Li","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"106342","DOI":"10.1016\/j.clineuro.2020.106342","article-title":"Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. a literature survey and discussion of a unique index case","volume":"200","author":"Elmaci","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41016-021-00233-5","article-title":"The protean manifestations of central nervous system IgG4-related hypertrophic pachymeningitis: A report of two cases","volume":"7","author":"Woo","year":"2021","journal-title":"Chin neurosurgical J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.329549","article-title":"IgG4-related disease in intradural extramedullary location- detailed case illustration and literature review with special emphasis on role of surgery in its management","volume":"69","author":"Sharma","year":"2021","journal-title":"Neurol India"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-021-01114-1","article-title":"Freiburg neuropathology case conference: A 56-year-old man presenting with progressive gait disorder, neck pain, and lower cranial nerve palsy","volume":"31","author":"Sankowski","year":"2021","journal-title":"Clin Neuroradiology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8863-1","article-title":"Idiopathic hypertrophic pachymeningitis: An autoimmune IgG4-related disease","volume":"65","author":"De Virgilio","year":"2017","journal-title":"Immunol Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/1941874418801088","article-title":"Neurologic IgG4-related disease","volume":"9","author":"Topiwala","year":"2019","journal-title":"Neurohospitalist"},{"key":"B47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/art.39132","article-title":"Autoimmune pancreatitis and IgG4-related systemic diseases","volume":"3","author":"Zhang","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Ann Rheumatol Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.276323","article-title":"Decoding epigenetic codes: New frontiers in exploring recovery from spinal cord injury","volume":"15","author":"Zhang","year":"2020","journal-title":"Neural Regeneration Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10926-7","article-title":"NFL During acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity","volume":"269","author":"Alcal\u00e1","year":"2022","journal-title":"J Neurol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/cei.12641","article-title":"Immunology of IgG4-related disease","volume":"181","author":"Della-Torre","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/art.33386","article-title":"Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheumatism"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0626-8","article-title":"Toll-like receptor activation in basophils contributes to the development of IgG4-related disease","volume":"48","author":"Watanabe","year":"2013","journal-title":"J Gastroenterol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment","volume":"71","author":"Lu","year":"2014","journal-title":"JAMA Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13075-017-1467-x","article-title":"New clues to the nature of immunoglobulin G4-related disease: A retrospective Japanese multicenter study of baseline clinical features of 334 cases","volume":"19","author":"Yamada","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12026-019-9070-7","article-title":"Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature","volume":"67","author":"Kawashima","year":"2019","journal-title":"Immunol Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24068","article-title":"Idiopathic multicentric castleman's disease: A clinicopathologic study in comparison with IgG4-related disease","volume":"9","author":"Otani","year":"2018","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/art.39686","article-title":"IgG4-related disease: retrospective analysis of one hundred sixty-six patients","volume":"68","author":"Sekiguchi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2015.1055796","article-title":"IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients","volume":"45","author":"Campochiaro","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003785","article-title":"Diagnostic value of serum IgG4 for IgG4-related disease: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Hao","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/art.38193","article-title":"Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease","volume":"66","author":"Khosroshahi","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11940-017-0450-9","article-title":"Neurological manifestations of IgG4-related disease","volume":"19","author":"Baptista","year":"2017","journal-title":"Curr Treat options Neurol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2015.03.035","article-title":"IgG4-related hypertrophic pachymeningitis at the falx cerebrii with brain parenchymal invasion: a case report","volume":"84","author":"Li","year":"2015","journal-title":"World Neurosurg"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316519","article-title":"Intrathecal rituximab for IgG(4)-related hypertrophic pachymeningitis","volume":"89","author":"Della-Torre","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302886","article-title":"Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo clinic experience","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1035056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T16:18:09Z","timestamp":1673367489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1035056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":69,"alternative-id":["10.3389\/fonc.2022.1035056"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1035056","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"article-number":"1035056"}}